Results
73,241 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Delco Albert BradEVP & CFO |  JBHTHUNT J B TRANSPORT SERVICES INCTax withholding | F | $23K 102 sh | Nov 2, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Delco Albert BradEVP & CFO | JBHTHUNT J B TRANSPORT SERVICES INC Tax withholding | F | $23K 102 sh | Nov 2, 2026 |
| 5 | Munsch FrederickSVP, Controller and CAO |  BLCOBausch & Lomb CorpOption exercise | M | — 24.1K sh | Nov 2, 2026 traded Oct 29, 2026 |
| 5 | Woodruff Ronald GreerEVP Safety, ESG, Maintenance | JBHTHUNT J B TRANSPORT SERVICES INC Option exercise | M | — 230 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 4 | Widman FredrikVP Corporate Controller |  ISRGINTUITIVE SURGICAL INCOption exercise · 10b5-1 plan | M | — 307 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 312 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Hansen GwennChief Scientific Officer |  NRIXNurix Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 3,750 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 307 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $43K 546 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Hyman JonathanChief Technology Officer |  BRZEBraze, Inc.Open-market sale · 10b5-1 plan | SELL | $915K 20.0K sh | Nov 2, 2026 traded Oct 29, 2026 |
| 1 | Canning Susan M.SVP, CLO, Corporate Secretary |  HAYWHayward Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $31K 2,000 sh | Nov 2, 2026 traded Oct 29, 2026 |
| 1 | Canning Susan M.SVP, CLO, Corporate Secretary | HAYWHayward Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $40K 2,500 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 262 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $45K 325 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 2,859 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $91K 312 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 325 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 263 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 567 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 312 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $57K 325 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $48K 263 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $101K 567 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $137K 567 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $100K 406 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $141K 406 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $65K 312 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 543 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 406 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 325 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 567 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 546 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $59K 543 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 406 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 3,750 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $2,701 1,452 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $70K 307 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 1,452 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $44K 262 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $94K 307 sh | Nov 2, 2026 traded Oct 30, 2026 |